Skip to main content
Top
Published in: European Journal of Nuclear Medicine and Molecular Imaging 4/2008

01-04-2008 | Editorial

GMP—three letters with many interpretations

Protection of patients or killing the clinical and research applications of PET?

Authors: Bengt Långström, Per Hartvig

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 4/2008

Login to get access

Excerpt

The purpose of good manufacturing practise (GMP) is not to place patients at risk due to inadequate safety and efficacy (and to hamper fraud) (Eudralex IV). These principles taken as long back as to Aristotle’s “not to do harm to patients” are non-inevitable and non-disputable. But, which is the best way to fulfil this in the production of radiopharmaceuticals particularly for those evolving to become the molecular tools for positron emission tomography (PET)? …
Metadata
Title
GMP—three letters with many interpretations
Protection of patients or killing the clinical and research applications of PET?
Authors
Bengt Långström
Per Hartvig
Publication date
01-04-2008
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 4/2008
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-007-0657-1

Other articles of this Issue 4/2008

European Journal of Nuclear Medicine and Molecular Imaging 4/2008 Go to the issue